Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTYH
4451
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $101K | ﹤0.01% |
24,382
+11,221
| +85% | +$43.8K |
|
4452
Fennec Pharmaceuticals
FENC
$365M
| $100K | ﹤0.01% |
+11,965
| New | +$89K |
|
4453
Harvard Bioscience
HBIO
$28.7M
| $100K | ﹤0.01% |
+3,214
| New | +$86.6K |
|
4454
CALL
MarketAxess Holdings
MKTX
$5.72B
| $100K | ﹤0.01% |
200
| – | – |
|
|
4455
PUT
MarketAxess Holdings
MKTX
$5.72B
| $100K | ﹤0.01% |
200
| – | – |
|
4456
Oil-Dri
ODC
$1.42B
| $100K | ﹤0.01% |
5,754
+2,276
| +65% | +$39.4K |
|
4457
PUT
Oneok
OKE
$55B
| $100K | ﹤0.01% |
3,000
-18,300
| -86% | -$596K |
|
|
CIT
4458
CALL
DELISTED
CIT Group Inc.
CIT
| $100K | ﹤0.01% |
4,800
-6,400
| -57% | -$124K |
|
4459
PUT
BHP
BHP
$227B
| $99K | ﹤0.01% |
2,242
-48,099
| -96% | -$1.88M |
|
4460
Boston Omaha
BOC
$438M
| $99K | ﹤0.01% |
6,184
+2,681
| +77% | +$44.8K |
|
4461
CALL
Qorvo
QRVO
$8.4B
| $99K | ﹤0.01% |
900
-15,600
| -95% | -$1.55M |
|
|
SIEN
4462
DELISTED
Sientra, Inc.
SIEN
| $99K | ﹤0.01% |
2,560
+1,280
| +100% | +$38.6K |
|
|
BELFB
4463
Bel Fuse Inc Class B
BELFB
$4.18B
| $98K | ﹤0.01% |
9,125
+812
| +10% | +$7.42K |
|
4464
PUT
Cheniere Energy
CQP
$31B
| $98K | ﹤0.01% |
2,800
-9,600
| -77% | -$321K |
|
4465
PUT
Edison International
EIX
$26.3B
| $98K | ﹤0.01% |
1,800
-30,500
| -94% | -$1.75M |
|
4466
PUT
ICICI Bank
IBN
$109B
| $98K | ﹤0.01% |
10,600
-50,400
| -83% | -$448K |
|
4467
Pure Cycle
PCYO
$255M
| $98K | ﹤0.01% |
10,597
+4,294
| +68% | +$42K |
|
4468
CALL
Pilgrim's Pride
PPC
$6.33B
| $98K | ﹤0.01% |
5,800
-2,900
| -33% | -$56.5K |
|
|
DSKE
4469
DELISTED
Daseke, Inc. Common Stock
DSKE
| $98K | ﹤0.01% |
24,997
+9,834
| +65% | +$21.6K |
|
4470
CALL
Air Products & Chemicals
APD
$65.7B
| $97K | ﹤0.01% |
400
-5,000
| -93% | -$1.14M |
|
|
4471
PUT
Air Products & Chemicals
APD
$65.7B
| $97K | ﹤0.01% |
400
-3,900
| -91% | -$890K |
|
4472
CALL
Ashland
ASH
$3.28B
| $97K | ﹤0.01% |
1,400
-2,000
| -59% | -$124K |
|
4473
AMES National
ATLO
$277M
| $97K | ﹤0.01% |
4,906
+1,969
| +67% | +$38.5K |
|
4474
CNA Financial
CNA
$14.2B
| $97K | ﹤0.01% |
2,995
-12,600
| -81% | -$388K |
|
4475
Gyre Therapeutics
GYRE
$695M
| $97K | ﹤0.01% |
2,213
+2,209
| +55,225% | +$104K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.